Amgen (AMGN) Could See $13 Benefit From NVS Breach - RBC
Tweet Send to a Friend
RBC Capital analyst Kennen MacKay reiterated a Sector Perform rating on Amgen (NASDAQ: AMGN) and sees potential for +$10-$13/sh to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
